Worsened blood circulation from autonomic dysfunction may contribute to depressive symptoms, offering a new avenue for treatment-resistant depression. The Healthy @Reader's Digest on MSN: Ketamine therapy: A medical doctor explains its use for treatment-resistant depression Patients with treatment-resistant depression who engaged in a single day of treatment with inhaled mebufotenin reported significant symptom improvements at 8 days and again at 6 months, according to ... Markets Insider: AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs Researchers from the United Kingdom recently studied whether a ketogenic (keto) diet, low in carbs, could help adults with treatment-resistant depression.
Depression is common in the United States, ... The American Journal of Managed Care: Esketamine Nasal Spray Shows Rapid, Durable Effectiveness in Treatment-Resistant Depression New real-world evidence on esketamine (Spravato; Janssen Pharmaceutical) nasal spray is reinforcing its role as an effective and durable treatment option for adults with treatment-resistant depression ... A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when other options fall short.
